Anti-cancer jab taking 7 minutes to administer rolled out in England
The Hindu
NHS England rolls out anti-cancer jab that cuts treatment time by 75%. Injection takes 7 mins, freeing up valuable time for NHS cancer teams. MHRA approved, 3,600 patients to switch to time-saving injection. Atezolizumab empowers patient's immune system to seek and destroy cancer cells. Faster injections make important difference for patients and clinicians.
An anti-cancer jab that can cut down treatment time for some by three quarters has been rolled out by National Health Service (NHS) England, the U.K.'s publicly funded healthcare system.
The jab takes as little as 7 minutes to administer, NHS England said in a statement, adding that it will be the first health system in the world to roll out the seven-minute injection to hundreds of NHS cancer patients each year.
The vaccine has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA), the statement said.
Explained | Why CAR T-cell therapy is cancer treatment’s next moonshot
MHRA is a U.K. state agency responsible for ensuring that medicines and medical devices work and are acceptably safe.
Currently, the patients receive the life-extending immunotherapy atezolizumab in hospital directly into their veins via a drug transfusion (intravenously), which can take from 30 minutes to up to an hour to administer, the statement said.
This anti-cancer jab, a subcutaneous or under-the-skin injection, is swifter and is expected to enhance the patients' experience, it said.
With a new government in place in Delhi, Singapore hopes to schedule the Ministerial Roundtable with India shortly, says Singapore Foreign Minister Vivian Balakrishnan. In an exclusive interview, he speaks about the impact of the elections on ties, the “missed opportunity” of RCEP and the new buzz around Andhra Pradesh’s capital Amaravati.